Université Laval Proposals

Canada Excellence Research Chair in Dysmetabolic Gut MicroBiota (DGMB)

Worldwide, the unrelenting rise and increasing ubiquity of obesity is alarming. What is more concerning is that despite scientific evidence of obesity’s association with a number of severe medical conditions (including diabetes and heart disease), we still know relatively little about the nature of this association. Very recently, gut microbiota—the various microorganisms living in digestive tracts—have been identified as a key element in the connection between obesity and its related complications. At Université Laval, the Canada Excellence Research Chair in Dysmetabolic Gut MicroBiota will lead a major research initiative into the complex relationships between microbiota, nutrition and obesity. The research aims to develop new and more effective therapeutic treatments to improve the health of Canadians.

Canada Excellence Research Chair in Neurophotonics

New non-invasive approaches, technologies, and instruments will enable the Chair in Neurophotonics to study the mysteries of the brain in the context of Alzheimer’s disease, Lou Gehrig’s disease, epilepsy and depression, as well as other disorders and diseases. By fostering the development of key advances in understanding brain function and enhancing neurosurgery and pharmacological resources, the Chair will help confirm Quebec City’s leadership in photonics, neuroscience and mental health, and will fuel innovative breakthroughs in biomedical technology.